Paper973986
The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.
Roberts CJ and 3 others. Br J Clin Pharmacol, 1976. Cited by 93 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. Papers, record 973986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/973986
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipyrine | Major topic |
| Indocyanine Green | Major topic |
| Liver | Major topic |
| Phenobarbital | Major topic |
| Adult | |
| Biotransformation | |
| Female | |
| Humans | |
| Liver Function Tests | |
| Male | |
| Ultrasonics |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13,844,597 | The use of indocyanine green for the evaluation of hepatic function and blood flow in man. | Am J Dig Dis | 1960 | https://conductscience.org/library/papers/13844597 | PubMed |
| 2 | 5,650,142 | Studies on the mechanism of phenobarbital-enhanced sulfobromophthalein disappearance. | J Pharmacol Exp Ther | 1968 | https://conductscience.org/library/papers/5650142 | PubMed |
| 3 | 13,809,697 | Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. | J Clin Invest | 1960 | https://conductscience.org/library/papers/13809697 | PubMed |
| 4 | 13,689,739 | The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. | Clin Sci | 1961 | https://conductscience.org/library/papers/13689739 | PubMed |
| 5 | 1,234,506 | Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man. | Br J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/1234506 | PubMed |
| 6 | 5,087,064 | The stimulant effect of drugs on indocyanine green clearance by the liver. | Gut | 1972 | https://conductscience.org/library/papers/5087064 | PubMed |
| 7 | 4,144,102 | Determination of drug metabolizing enzymes in needle biopsies of human liver. | Eur J Clin Pharmacol | 1972 | https://conductscience.org/library/papers/4144102 | PubMed |
| 8 | 4,150,321 | Relationship between plasma antipyrine half-lives and hepatic microsomal drug metabolism in dogs. | Pharmacology | 1973 | https://conductscience.org/library/papers/4150321 | PubMed |
| 9 | 4,205,524 | Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. | J Clin Invest | 1974 | https://conductscience.org/library/papers/4205524 | PubMed |
| 10 | 4,428,060 | Quantitation of tumor volumes and response to therapy with ultrasound B-scans. | Radiology | 1974 | https://conductscience.org/library/papers/4428060 | PubMed |
| 11 | 4,784,365 | Plasma antipyrine half-life and hepatic microsomal antipyrine hydroxylase activity in rabbits. | Pharmacology | 1973 | https://conductscience.org/library/papers/4784365 | PubMed |
| 12 | 4,746,322 | Hemodynamic drug interactions: the reduction of oxyphenbutazone clearance by dl-propranol in the dog. | J Pharmacol Exp Ther | 1973 | https://conductscience.org/library/papers/4746322 | PubMed |
| 13 | 4,698,657 | Hepatic bilirubin UDP-glucuronyl transferase activity and cytochrome P450 content in a surgical population, and the effects of preoperative drug therapy. | J Lab Clin Med | 1973 | https://conductscience.org/library/papers/4698657 | PubMed |
| 14 | 5,045,968 | Liver volume determination by ultrasonic scanning. | Br J Radiol | 1972 | https://conductscience.org/library/papers/5045968 | PubMed |
| 15 | 5,114,497 | Changes in liver blood flow during enzyme induction. | Biochem Pharmacol | 1971 | https://conductscience.org/library/papers/5114497 | PubMed |
| 16 | 5,389,794 | Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man. | J Clin Invest | 1969 | https://conductscience.org/library/papers/5389794 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,063,098 | Analysis of Carcinogenic Involvement of MicroRNA Pattern in Peripheral Non-Cancerous Tissues and Chronic Viral Liver Injury. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39063098 | PubMed |
| 34,880,776 | Physiologically Based Modeling of the Effect of Physiological and Anthropometric Variability on Indocyanine Green Based Liver Function Tests. | Front Physiol | 2021 | https://conductscience.org/library/papers/34880776 | PubMed |
| 11,392,451 | Body surface area as a determinant of pharmacokinetics and drug dosing. | Invest New Drugs | 2001 | https://conductscience.org/library/papers/11392451 | PubMed |
| 9,833,597 | Relationships among liver and kidney volumes, lean body mass and drug clearance. | Br J Clin Pharmacol | 1998 | https://conductscience.org/library/papers/9833597 | PubMed |
| 8,491,059 | Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8491059 | PubMed |
| 8,013,162 | Lean body mass as a predictor of drug dosage. Implications for drug therapy. | Clin Pharmacokinet | 1994 | https://conductscience.org/library/papers/8013162 | PubMed |
| 7,737,036 | Pharmacokinetics in the elderly. | Environ Health Perspect | 1994 | https://conductscience.org/library/papers/7737036 | PubMed |
| 7,389,235 | Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine. | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/7389235 | PubMed |
| 7,389,234 | Antipyrine half-life and drug elimination. | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/7389234 | PubMed |
| 7,333,060 | Disposition of antipyrine and phenytoin correlated with age and liver volume in man. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/7333060 | PubMed |
| 7,117,357 | Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7117357 | PubMed |
| 7,082,041 | Liver volume estimation using ultrasound scanning. | Arch Dis Child | 1982 | https://conductscience.org/library/papers/7082041 | PubMed |
| 7,059,438 | Differential effects of enzyme induction on antipyrine metabolite formation. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7059438 | PubMed |
| 6,861,869 | Relationships between plasma theophylline clearance, liver volume and body weight in children and adults. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6861869 | PubMed |
| 6,849,748 | A link between liver microsomal enzyme activity and thyroid hormone metabolism in man. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6849748 | PubMed |
| 6,832,206 | Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6832206 | PubMed |
| 6,693,040 | Effects of chronic oral cimetidine on apparent liver blood flow and hepatic microsomal enzyme activity in man. | Gut | 1984 | https://conductscience.org/library/papers/6693040 | PubMed |
| 6,628,504 | Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6628504 | PubMed |
| 6,508,980 | Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6508980 | PubMed |
| 6,487,478 | The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6487478 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/973986
GET https://conductscience.org/api/papers/v1/973986/cited_by?page=2